Sort by
Keyphrases
Sickle Cell Disease
100%
Stem Cell Transplantation
100%
Hematopoietic SCT
100%
Supportive Care
22%
United States
11%
Poor Quality of Life
11%
Overall Survival
11%
Marrow Transplantation
11%
Medical Care
11%
Conditioning Regimen
11%
Early Mortality
11%
Treatment Modalities
11%
Organ Damage
11%
Risk-benefit Ratio
11%
Medical Support
11%
Normal Hematopoiesis
11%
Low Toxicity
11%
HLA-matched Donor
11%
Unrelated Donor
11%
Matched Donors
11%
Transplant Complications
11%
Physician Perspective
11%
New Predictor
11%
Medicine and Dentistry
Stem Cell Therapy
100%
Sickle-Cell Disease
100%
Supportive Care
50%
Diseases
50%
Overall Survival
25%
Quality of Life
25%
Conditioning
25%
Hematopoiesis
25%
Medical Care
25%
Anticipation
25%
Risk-Benefit Ratio
25%
Matched Donor
25%
Treatment Modality
25%
Nursing and Health Professions
Stem Cell Therapy
100%
Sickle Cell Anemia
100%
Diseases
50%
Overall Survival
25%
Matched Donor
25%
Health Care
25%
Quality of Life
25%